These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 598566)

  • 1. Inhibition of L-dopa induced growth hormone release in normal and diabetic subjects by glucose administration.
    Vigas M; Klimes I; Jurcovicova J; Kolesar P; Repcekova-Jezova D
    Diabete Metab; 1977 Dec; 3(4):257-8. PubMed ID: 598566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRH-induced growth hormone release in insulin-dependent diabetes mellitus.
    Krassowski J; Jeske W; Zgliczyński S
    Horm Metab Res; 1984 Dec; 16 Suppl 1():119-22. PubMed ID: 6442706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of l-dopa on growth hormone, glucose, insulin, and cortisol response in obese subjects.
    Vizner B; Reiner Z; Sekso M
    Exp Clin Endocrinol; 1983 Jan; 81(1):41-8. PubMed ID: 6343098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hyperglycemia on the growth hormone response to L-dopa in diabetic subjects.
    Barbarino A; De Marinis L; Martino F
    J Endocrinol Invest; 1978 Jul; 1(3):259-61. PubMed ID: 756876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
    Hansen AP; Christensen SE; Lundbaek K
    Scand J Clin Lab Invest; 1975 May; 35(3):205-10. PubMed ID: 1153917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of sustained hyperglycemia on GHRH induced GH secretion in man.
    Garrel DR; Bajard L; Harfouche M; Tourniaire J
    Diabete Metab; 1989; 15(5):251-4. PubMed ID: 2517116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on growth hormone and prolactin secretions in myotonic dystrophy.
    Canal N; Smirne S; Comi G; Guidobono F; Pecile A; Caviezel F
    Acta Neurol Belg; 1982; 82(3):178-84. PubMed ID: 7051737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does gonadotropin-releasing hormone administration affect serum growth hormone levels in poorly controlled insulin-dependent and non-insulin-dependent diabetes mellitus?
    Gürlek A; Yordam N; Telatar F
    Isr J Med Sci; 1995 Nov; 31(11):685-9. PubMed ID: 7591703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of glucose on the glucagon response to L-dopa in normal and diabetic subjects.
    Klimes I; Vigas M; Jurcovicová J; Repceková D; Kolesár P
    Diabetes; 1978 Apr; 27(4):396-9. PubMed ID: 640244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal growth hormone responsiveness to stimuli in women with active celiac sprue.
    Peracchi M; Molteni N; Cantalamessa L; Bardella MT; Peracchi G; Orsatti A; Faggioli P; Bianchi PA
    Am J Gastroenterol; 1992 May; 87(5):580-3. PubMed ID: 1595643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginine abolishes the inhibitory effect of glucose on the growth hormone response to growth hormone-releasing hormone in man.
    Ghigo E; Miola C; Aimaretti G; Valente F; Procopio M; Arvat E; Yin-Zhang W; Camanni F
    Metabolism; 1992 Sep; 41(9):1000-3. PubMed ID: 1355580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of growth hormone releasing hormone on growth hormone, prostaglandin E2 and insulin in non-insulin-dependent diabetic patients.
    Koev D; Zacharieva S; Popova J; Andonova K
    Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):137-40. PubMed ID: 8740245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of L-dopa-induced growth hormone stimulation by pyridoxine and chlorpromazine.
    Mims RB; Scott CL; Modebe O; Bethune JE
    J Clin Endocrinol Metab; 1975 Feb; 40(2):256-9. PubMed ID: 1117978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of L-dopa administration on insulin binding: possible role of growth hormone in regulation of insulin receptor affinity.
    Iwasaki M; Kobayashi M; Ohgaku S; Maegawa H; Shigeta Y
    Horm Metab Res; 1982 Jul; 14(7):342-5. PubMed ID: 6749630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of glucose on the growth hormone response to L-dopa in normal and diabetic subjects.
    Ajlouni K; Martinson DR; Hagen TC
    Diabetes; 1975 Jul; 24(7):633-6. PubMed ID: 1158029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of acute hypercalcaemia on arginine induced growth hormone release in diabetic man.
    Kaplan PW; Jung RT
    Horm Metab Res; 1984 Dec; 16 Suppl 1():123-6. PubMed ID: 6532933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Method of determination of somatotropin level in blood plasma with L-dopa loading in patients with diabetes mellitus complicated by microangiopathies].
    Babakhanov KhB
    Lab Delo; 1975; (10):605-7. PubMed ID: 54462
    [No Abstract]   [Full Text] [Related]  

  • 18. [A low response of pituitary growth hormone secretion in the patient with diabetes mellitus after intravenous administration of L-dopa (author's transl)].
    Shimoda S; Takemura Y; Ieiri T; Kasai K; Kikuchi T
    Nihon Naibunpi Gakkai Zasshi; 1975 Jan; 51(1):9-17. PubMed ID: 1171032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinergic receptor control mechanisms for L-dopa, apomorphine, and clonidine-induced growth hormone secretion in man.
    Delitala G; Maioli M; Pacifico A; Brianda S; Palermo M; Mannelli M
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1145-9. PubMed ID: 6688812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the mechanism of hyperglycemia and stimulation of growth hormone secretion by L-dopa.
    Hampshire J; Moraru E; Altszuler N
    Pharmacology; 1978; 17(3):138-48. PubMed ID: 704657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.